| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-89 |
Sentence |
denotes |
DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy. |
| T1 |
0-89 |
Sentence |
denotes |
DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy. |
| TextSentencer_T2 |
90-101 |
Sentence |
denotes |
BACKGROUND: |
| T2 |
90-101 |
Sentence |
denotes |
BACKGROUND: |
| TextSentencer_T3 |
102-250 |
Sentence |
denotes |
Aristolochic acid-associated nephropathy (AAN) is a specific type of renal disease that predisposes patients to a high risk of urothelial carcinoma. |
| T3 |
102-250 |
Sentence |
denotes |
Aristolochic acid-associated nephropathy (AAN) is a specific type of renal disease that predisposes patients to a high risk of urothelial carcinoma. |
| TextSentencer_T4 |
251-424 |
Sentence |
denotes |
The authors have analyzed DNA from a patient who had urothelial malignancy 6 years after presenting with AAN and later had a breast carcinoma that metastasized to the liver. |
| T4 |
251-424 |
Sentence |
denotes |
The authors have analyzed DNA from a patient who had urothelial malignancy 6 years after presenting with AAN and later had a breast carcinoma that metastasized to the liver. |
| TextSentencer_T5 |
425-631 |
Sentence |
denotes |
METHODS AND RESULTS: DNA was isolated from the primary breast tumor, the liver tumor, and the original urothelial malignancy and assayed for aristolochic acid (AA)-DNA adducts and mutations in the p53 gene. |
| T5 |
425-631 |
Sentence |
denotes |
METHODS AND RESULTS: DNA was isolated from the primary breast tumor, the liver tumor, and the original urothelial malignancy and assayed for aristolochic acid (AA)-DNA adducts and mutations in the p53 gene. |
| TextSentencer_T6 |
632-747 |
Sentence |
denotes |
The adduct detected was the adenosine adduct of aristolochic acid I 7-(deoxyadenosin-N6-yl)aristolactam I (dA-AAI). |
| T6 |
632-747 |
Sentence |
denotes |
The adduct detected was the adenosine adduct of aristolochic acid I 7-(deoxyadenosin-N6-yl)aristolactam I (dA-AAI). |
| TextSentencer_T7 |
748-887 |
Sentence |
denotes |
In DNA from the breast and liver tumors the authors showed the same missense mutation in codon 245 (GGC-->GAC; Gly-->Asp) of exon 7 of p53. |
| T7 |
748-887 |
Sentence |
denotes |
In DNA from the breast and liver tumors the authors showed the same missense mutation in codon 245 (GGC-->GAC; Gly-->Asp) of exon 7 of p53. |
| TextSentencer_T8 |
888-1007 |
Sentence |
denotes |
In contrast, DNA extracted from the urothelial tumor showed an AAG to TAG mutation in codon 139 (Lys-->Stop) of exon 5. |
| T8 |
888-1007 |
Sentence |
denotes |
In contrast, DNA extracted from the urothelial tumor showed an AAG to TAG mutation in codon 139 (Lys-->Stop) of exon 5. |
| TextSentencer_T9 |
1008-1019 |
Sentence |
denotes |
CONCLUSION: |
| T9 |
1008-1019 |
Sentence |
denotes |
CONCLUSION: |
| TextSentencer_T10 |
1020-1227 |
Sentence |
denotes |
A to T transversions, as observed here, are the typical mutations observed in the H-ras gene of tumors induced when rodents are treated with AA and correspond with DNA adduct formation at adenosine residues. |
| T10 |
1020-1227 |
Sentence |
denotes |
A to T transversions, as observed here, are the typical mutations observed in the H-ras gene of tumors induced when rodents are treated with AA and correspond with DNA adduct formation at adenosine residues. |
| TextSentencer_T11 |
1228-1321 |
Sentence |
denotes |
These data indicate the probable molecular mechanism whereby AA causes urothelial malignancy. |
| T11 |
1228-1321 |
Sentence |
denotes |
These data indicate the probable molecular mechanism whereby AA causes urothelial malignancy. |